PetMed Express Inc.

NASDAQ: PETS · Real-Time Price · USD
3.07
-0.03 (-0.97%)
At close: Aug 15, 2025, 12:23 PM

PetMed Express Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Revenue
247.01M 259.34M 270.77M 281.06M 276.97M 270.52M 264.92M 256.86M 260.45M 262.3M 264.29M 273.42M 279.09M 284.27M 292.32M 309.21M 311.82M 305.84M 300.34M
Cost of Revenue
182.26M 192.59M 201.26M 205.28M 200.08M 195.31M 191.32M 185.84M 187.42M 186.78M 188.05M 195.34M 199.89M 203.17M 207.38M 219.27M 220.71M 216.66M 214.17M
Gross Profit
64.75M 66.76M 69.51M 75.78M 76.88M 75.21M 73.6M 71.01M 73.03M 75.52M 76.24M 78.08M 79.2M 81.1M 84.94M 89.95M 91.11M 89.19M 86.17M
Operating Income
655K -1.97M -2.96M -9.48M -12.76M -10.45M -7.05M -1.43M 12.74M 18.66M 23.78M 25.71M 27.04M 31.19M 33.57M 37.59M 37.71M 36.35M 34.25M
Interest Income
338K 446K 831K 930K 1.76M 1.92M 1.74M 1.66M 896K 681K 367K 335K 328K 317K 309K 314K 529K 877K 1.27M
Pretax Income
1.92M -488K -1.03M -6.74M -9.29M -6.45M -3.22M 1.58M 15.05M 20.37M 25.09M 27.07M 28.49M 32.68M 35.22M 39.22M 39.49M 38.43M 36.69M
Net Income
357K -963K -3.36M -8M -8.09M -6.08M -3.43M 233K 11.4M 15.68M 19.45M 21.1M 21.85M 25.2M 27.26M 30.6M 30.79M 30.02M 28.28M
Selling & General & Admin
60.95M 66.37M 68.74M 79.85M 83.14M 79.02M 76.17M 68.9M 57.05M 53.85M 49.61M 49.63M 49.47M 47.31M 48.86M 49.93M 51.05M 50.55M 49.67M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
3.24M 1.66M 1.71M 2.22M 3.21M 4.15M 3.3M 3.55M 3.24M 2.58M 1.9M 1.43M 1.12M 1.18M 1.34M 1.31M 1.25M 1.2M 1.17M
Operating Expenses
64.2M 68.03M 70.45M 83.25M 87.52M 84.34M 80.64M 72.44M 60.29M 56.86M 52.46M 52.37M 52.16M 49.91M 51.37M 52.36M 53.4M 52.83M 51.92M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a 117K 117K 117K 117K n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
20.55M 23.33M 24.23M 24.51M 23.09M 21.97M 20.34M 19.42M 18.23M 17.92M 17.48M 18.8M 19.69M 18.59M 20.28M 21.64M 23.59M 23.53M 23.16M
Cost & Expenses
246.46M 261.41M 273.84M 290.64M 289.72M 280.97M 271.96M 258.29M 247.71M 243.65M 240.51M 247.71M 252.05M 253.09M 258.75M 271.63M 274.11M 269.49M 266.09M
Income Tax Expense
1.56M 475K 2.33M 1.26M -1.21M -372K 206K 1.35M 3.65M 4.69M 5.64M 5.97M 6.64M 7.48M 7.96M 8.61M 8.69M 8.41M 8.41M
Shares Outstanding (Basic)
20.63M 20.6M 20.51M 20.44M 20.43M 20.38M 20.33M 20.33M 20.3M 20.26M 20.21M 20.21M 20.21M 20.18M 20.11M 20.1M 20.09M 20.06M 19.98M
Shares Outstanding (Diluted)
20.63M 20.94M 20.94M 20.44M 20.43M 20.38M 20.33M 20.34M 20.3M 20.34M 20.29M 20.34M 20.33M 20.57M 20.2M 20.18M 20.1M 20.15M 20.04M
EPS (Basic)
0.01 -0.06 -0.17 -0.4 -0.4 -0.3 -0.16 0.02 0.57 0.78 0.96 1.04 1.08 1.25 1.36 1.53 1.54 1.50 1.41
EPS (Diluted)
0.01 -0.06 -0.17 -0.4 -0.4 -0.3 -0.16 0.02 0.57 0.78 0.96 1.04 1.08 1.25 1.36 1.53 1.54 1.50 1.41
EBITDA
7.51M 5.08M 5.86M -701K -4.88M -3.4M -2.58M 2.12M 15.98M 21.66M 26.63M 28.45M 29.73M 33.78M 36.08M 40.01M 40.06M 38.64M 36.5M
EBIT
655K -1.97M -1.24M -7.76M -11.03M -8.73M -7.05M -1.61M 12.94M 19.22M 24.59M 27.07M 28.49M 32.68M 35.22M 39.22M 39.49M 38.43M 36.69M
Depreciation & Amortization
6.86M 7.04M 7.1M 7.06M 6.16M 5.33M 4.47M 3.55M 3.24M 3.01M 2.84M 2.74M 2.69M 2.6M 2.51M 2.43M 2.35M 2.29M 2.25M